Evidence map›Paper›PMID 36105388›Full record

ArticleNeuro-oncology advances

Automated detection and quantification of brain metastases on clinical MRI data using artificial neural networks.

Irada Pflüger, Tassilo Wald, Fabian Isensee, Marianne Schell, Hagen Meredig, Kai Schlamp, Denise Bernhardt, Gianluca Brugnara, Claus Peter Heußel, Juergen Debus and 4 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Principles of artificial intelligence in radiooncology.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  6. Article
  7. Enhanced nnU-Net Architectures for Automated MRI Segmentation of Head and Neck Tumors in Adaptive Radiation Therapy.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Irada PflügerDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Tassilo WaldMedical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fabian IsenseeMedical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marianne SchellDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Hagen MeredigDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Kai SchlampDepartment of Diagnostic and Interventional Radiology with Nuclear Medicine, Clinic for Thoracic Diseases (Thoraxklinik), Heidelberg University Hospital, Heidelberg, Germany.
Denise BernhardtDepartment of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-5231-9097
Gianluca BrugnaraDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Claus Peter HeußelDepartment of Diagnostic and Interventional Radiology with Nuclear Medicine, Clinic for Thoracic Diseases (Thoraxklinik), Heidelberg University Hospital, Heidelberg, Germany.
Juergen DebusDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Wolfgang WickNeurology Clinic, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-6171-634X
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-9094-6769
Klaus H Maier-HeinMedical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Philipp VollmuthDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-6224-0064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Reliable detection and precise volumetric quantification of brain metastases (BM) on MRI are essential for guiding treatment decisions. Here we evaluate the potential of artificial neural networks (ANN) for automated detection and quantification of BM. Methods: A consecutive series of 308 patients with BM was used for developing an ANN (with a 4:1 split for training/testing) for automated volumetric assessment of contrast-enhancing tumors (CE) and non-enhancing FLAIR signal abnormality including edema (NEE). An independent consecutive series of 30 patients was used for external testing. Performance was assessed case-wise for CE and NEE and lesion-wise for CE using the case-wise/lesion-wise DICE-coefficient (C/L-DICE), positive predictive value (L-PPV) and sensitivity (C/L-Sensitivity). Results: The performance of detecting CE lesions on the validation dataset was not significantly affected when evaluating different volumetric thresholds (0.001-0.2 cm Conclusion: The developed ANN-based algorithm (publicly available at www.github.com/NeuroAI-HD/HD-BM) allows reliable detection and precise volumetric quantification of CE and NEE compartments in patients with BM.

Indexed as

artificial intelligenceartificial neural networkbrain metastasismagnetic resonance imagingneuro-Oncology

Identifiers

PMID36105388
PMCPMC9466273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.